i3 Health
@i3health.bsky.social
i3 Health is a jointly accredited provider of #CME #NCPD #CPE for the interprofessional #healthcare team.
Enhance your expertise with i3 Health’s premium activities!
Access expert-led courses offering cutting-edge insights and #CME/NCPD credits.
Explore now at i3health.com!
Access expert-led courses offering cutting-edge insights and #CME/NCPD credits.
Explore now at i3health.com!
May 28, 2025 at 6:18 PM
Enhance your expertise with i3 Health’s premium activities!
Access expert-led courses offering cutting-edge insights and #CME/NCPD credits.
Explore now at i3health.com!
Access expert-led courses offering cutting-edge insights and #CME/NCPD credits.
Explore now at i3health.com!
May is National Mental Health Month!
Join us in raising awareness about the importance of mental health and breaking the stigma surrounding mental illness. Together, we can support patients, caregivers, and healthcare professionals in prioritizing mental well-being.
#MentalHealth #BreakTheStigma
Join us in raising awareness about the importance of mental health and breaking the stigma surrounding mental illness. Together, we can support patients, caregivers, and healthcare professionals in prioritizing mental well-being.
#MentalHealth #BreakTheStigma
May 19, 2025 at 2:13 PM
May is National Mental Health Month!
Join us in raising awareness about the importance of mental health and breaking the stigma surrounding mental illness. Together, we can support patients, caregivers, and healthcare professionals in prioritizing mental well-being.
#MentalHealth #BreakTheStigma
Join us in raising awareness about the importance of mental health and breaking the stigma surrounding mental illness. Together, we can support patients, caregivers, and healthcare professionals in prioritizing mental well-being.
#MentalHealth #BreakTheStigma
What can #TheWhiteLotus teach us about cancer care? 🏝️ Dr. Rahul Banerjee, explores “time toxicity” and why every patient’s journey is unique. How can we better tailor care? Read more: ow.ly/lqjr50VM5zO #Oncology #PatientCare
What the Oncology Field Can Learn From The White Lotus
Editor in Chief Dr. Rahul Banerjee's April Letter from the Editor explains what the oncology field can learn from "The White Lotus."
ow.ly
May 7, 2025 at 6:35 PM
What can #TheWhiteLotus teach us about cancer care? 🏝️ Dr. Rahul Banerjee, explores “time toxicity” and why every patient’s journey is unique. How can we better tailor care? Read more: ow.ly/lqjr50VM5zO #Oncology #PatientCare
MCED tests are redefining cancer care.
Learn about clinical trial data and strategies for integration in module 2 of this activity: youtube.com/watch?v=A2l0...
#MCED #CancerScreening
Learn about clinical trial data and strategies for integration in module 2 of this activity: youtube.com/watch?v=A2l0...
#MCED #CancerScreening
https://youtube.com/watch?v=A2l0NJLauCI…
April 27, 2025 at 8:40 PM
MCED tests are redefining cancer care.
Learn about clinical trial data and strategies for integration in module 2 of this activity: youtube.com/watch?v=A2l0...
#MCED #CancerScreening
Learn about clinical trial data and strategies for integration in module 2 of this activity: youtube.com/watch?v=A2l0...
#MCED #CancerScreening
Targeted therapies are offering new possibilities in NSCLC care.
Learn about advancements and strategies to improve outcomes in this activity.
Stay informed: bit.ly/4g5DUqO
#NSCLC #TargetedTherapies #Oncology
Learn about advancements and strategies to improve outcomes in this activity.
Stay informed: bit.ly/4g5DUqO
#NSCLC #TargetedTherapies #Oncology
April 23, 2025 at 3:41 PM
Targeted therapies are offering new possibilities in NSCLC care.
Learn about advancements and strategies to improve outcomes in this activity.
Stay informed: bit.ly/4g5DUqO
#NSCLC #TargetedTherapies #Oncology
Learn about advancements and strategies to improve outcomes in this activity.
Stay informed: bit.ly/4g5DUqO
#NSCLC #TargetedTherapies #Oncology
Discover the latest in hemophilia care.
This podcast explores new therapies and strategies to address inhibitors and enhance outcomes for patients.
Listen now: bit.ly/4biXnRD
#Hemophilia #CME #Oncology
This podcast explores new therapies and strategies to address inhibitors and enhance outcomes for patients.
Listen now: bit.ly/4biXnRD
#Hemophilia #CME #Oncology
April 21, 2025 at 4:18 PM
Discover the latest in hemophilia care.
This podcast explores new therapies and strategies to address inhibitors and enhance outcomes for patients.
Listen now: bit.ly/4biXnRD
#Hemophilia #CME #Oncology
This podcast explores new therapies and strategies to address inhibitors and enhance outcomes for patients.
Listen now: bit.ly/4biXnRD
#Hemophilia #CME #Oncology
April is National Minority Health Month, a time to raise awareness about health disparities and promote equity in healthcare.
Join us in advancing health equity this month and beyond.
#NationalMinorityHealthMonth #HealthEquity #CME #HealthcareEducation
Join us in advancing health equity this month and beyond.
#NationalMinorityHealthMonth #HealthEquity #CME #HealthcareEducation
April 19, 2025 at 2:20 PM
April is National Minority Health Month, a time to raise awareness about health disparities and promote equity in healthcare.
Join us in advancing health equity this month and beyond.
#NationalMinorityHealthMonth #HealthEquity #CME #HealthcareEducation
Join us in advancing health equity this month and beyond.
#NationalMinorityHealthMonth #HealthEquity #CME #HealthcareEducation
Spring savings are here! Use code SPRING50 for 50% off i3 Health’s premium activities and earn valuable CME/NCPD credits.
Start now at i3health.com
#SpringSavings #CME #HealthcareLearning
Start now at i3health.com
#SpringSavings #CME #HealthcareLearning
April 17, 2025 at 2:00 PM
Spring savings are here! Use code SPRING50 for 50% off i3 Health’s premium activities and earn valuable CME/NCPD credits.
Start now at i3health.com
#SpringSavings #CME #HealthcareLearning
Start now at i3health.com
#SpringSavings #CME #HealthcareLearning
T2DM and obesity are closely linked conditions with serious health impacts.
Learn about glucose-lowering medications, novel anti-obesity therapies, and emerging agents for managing both conditions in this activity.
Start now: bit.ly/4bW5PIm
#Diabetes #Obesity #CME
Learn about glucose-lowering medications, novel anti-obesity therapies, and emerging agents for managing both conditions in this activity.
Start now: bit.ly/4bW5PIm
#Diabetes #Obesity #CME
April 14, 2025 at 3:16 PM
T2DM and obesity are closely linked conditions with serious health impacts.
Learn about glucose-lowering medications, novel anti-obesity therapies, and emerging agents for managing both conditions in this activity.
Start now: bit.ly/4bW5PIm
#Diabetes #Obesity #CME
Learn about glucose-lowering medications, novel anti-obesity therapies, and emerging agents for managing both conditions in this activity.
Start now: bit.ly/4bW5PIm
#Diabetes #Obesity #CME
Learn how to manage opioid-induced constipation (OIC) with the latest strategies and emerging therapies.
Start now: bit.ly/42ehrSJ
#OIC #PainManagement #CME
Start now: bit.ly/42ehrSJ
#OIC #PainManagement #CME
April 7, 2025 at 3:06 PM
Learn how to manage opioid-induced constipation (OIC) with the latest strategies and emerging therapies.
Start now: bit.ly/42ehrSJ
#OIC #PainManagement #CME
Start now: bit.ly/42ehrSJ
#OIC #PainManagement #CME
Take your learning on the go with the i3 Health app!
Access accredited education, track your progress, and stay updated with the latest in healthcare—all from your mobile device.
Download now: app.i3health.com
#CME #HealthcareEducation #i3HealthApp
Access accredited education, track your progress, and stay updated with the latest in healthcare—all from your mobile device.
Download now: app.i3health.com
#CME #HealthcareEducation #i3HealthApp
April 3, 2025 at 4:25 PM
Take your learning on the go with the i3 Health app!
Access accredited education, track your progress, and stay updated with the latest in healthcare—all from your mobile device.
Download now: app.i3health.com
#CME #HealthcareEducation #i3HealthApp
Access accredited education, track your progress, and stay updated with the latest in healthcare—all from your mobile device.
Download now: app.i3health.com
#CME #HealthcareEducation #i3HealthApp
🚨 Expiring TODAY! Don’t miss this HNSCC activity featuring insights on immunotherapy advances and multidisciplinary care strategies.
Complete it now: bit.ly/3J6bD4E
#HNSCC #OncologyEducation #LastChance
Complete it now: bit.ly/3J6bD4E
#HNSCC #OncologyEducation #LastChance
April 2, 2025 at 12:38 PM
🚨 Expiring TODAY! Don’t miss this HNSCC activity featuring insights on immunotherapy advances and multidisciplinary care strategies.
Complete it now: bit.ly/3J6bD4E
#HNSCC #OncologyEducation #LastChance
Complete it now: bit.ly/3J6bD4E
#HNSCC #OncologyEducation #LastChance
Explore the latest therapies for atopic dermatitis in children and adolescents, including JAK inhibitors and monoclonal antibodies.
Start learning today: bit.ly/3ZnLgyI
#AtopicDermatitis #Dermatology
Start learning today: bit.ly/3ZnLgyI
#AtopicDermatitis #Dermatology
March 31, 2025 at 1:32 PM
Explore the latest therapies for atopic dermatitis in children and adolescents, including JAK inhibitors and monoclonal antibodies.
Start learning today: bit.ly/3ZnLgyI
#AtopicDermatitis #Dermatology
Start learning today: bit.ly/3ZnLgyI
#AtopicDermatitis #Dermatology
Learn how to optimize immunotherapy for recurrent/metastatic HNSCC with expert insights from Dr. Glenn Hanna and Dr. Deborah Wong.
Download the slide deck for key takeaways and actionable strategies: bit.ly/4ilGhH2 #HNSCC
Download the slide deck for key takeaways and actionable strategies: bit.ly/4ilGhH2 #HNSCC
March 26, 2025 at 4:54 PM
Learn how to optimize immunotherapy for recurrent/metastatic HNSCC with expert insights from Dr. Glenn Hanna and Dr. Deborah Wong.
Download the slide deck for key takeaways and actionable strategies: bit.ly/4ilGhH2 #HNSCC
Download the slide deck for key takeaways and actionable strategies: bit.ly/4ilGhH2 #HNSCC
Spring savings are here! 🌸
Use coupon code SPRING50 to get 50% off i3 Health’s premium activities. Enhance your expertise today: i3health.com
#HealthcareEducation
Use coupon code SPRING50 to get 50% off i3 Health’s premium activities. Enhance your expertise today: i3health.com
#HealthcareEducation
March 19, 2025 at 12:48 PM
Spring savings are here! 🌸
Use coupon code SPRING50 to get 50% off i3 Health’s premium activities. Enhance your expertise today: i3health.com
#HealthcareEducation
Use coupon code SPRING50 to get 50% off i3 Health’s premium activities. Enhance your expertise today: i3health.com
#HealthcareEducation
On Rare Disease Day, Oncology Data Advisor hosted a panel discussion on rare diseases, including uveal melanoma and plasma cell leukemia.
Experts shared insights on challenges, advances, and the patient perspective in rare disease care.
Watch now: www.youtube.com/live/zIs8bEd...
#RareDiseaseDay
Experts shared insights on challenges, advances, and the patient perspective in rare disease care.
Watch now: www.youtube.com/live/zIs8bEd...
#RareDiseaseDay
Rare Disease Day 2025: Generating Change Through Patient-Centered Care
YouTube video by Oncology Data Advisor
www.youtube.com
March 18, 2025 at 12:05 PM
On Rare Disease Day, Oncology Data Advisor hosted a panel discussion on rare diseases, including uveal melanoma and plasma cell leukemia.
Experts shared insights on challenges, advances, and the patient perspective in rare disease care.
Watch now: www.youtube.com/live/zIs8bEd...
#RareDiseaseDay
Experts shared insights on challenges, advances, and the patient perspective in rare disease care.
Watch now: www.youtube.com/live/zIs8bEd...
#RareDiseaseDay
Type 2 diabetes and obesity are interconnected conditions with significant health risks.
This activity highlights the potential of medications for managing both, including glucose-lowering drugs and emerging anti-obesity treatments.
Start the activity now: bit.ly/4bW5PIm
#Diabetes
This activity highlights the potential of medications for managing both, including glucose-lowering drugs and emerging anti-obesity treatments.
Start the activity now: bit.ly/4bW5PIm
#Diabetes
March 17, 2025 at 9:38 PM
Type 2 diabetes and obesity are interconnected conditions with significant health risks.
This activity highlights the potential of medications for managing both, including glucose-lowering drugs and emerging anti-obesity treatments.
Start the activity now: bit.ly/4bW5PIm
#Diabetes
This activity highlights the potential of medications for managing both, including glucose-lowering drugs and emerging anti-obesity treatments.
Start the activity now: bit.ly/4bW5PIm
#Diabetes
March is Kidney Cancer Awareness Month! In 2025, 80,980 new cases of kidney/renal pelvis cancer are expected in the US. Learn about the latest advances in RCC research in our interview with Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC. 🎥 Watch here: ow.ly/kGh550VihIm
March 17, 2025 at 12:26 PM
March is Kidney Cancer Awareness Month! In 2025, 80,980 new cases of kidney/renal pelvis cancer are expected in the US. Learn about the latest advances in RCC research in our interview with Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC. 🎥 Watch here: ow.ly/kGh550VihIm
How will the CheckMate 8HW trial impact the treatment of metastatic colorectal cancer (MSI-H/dMMR)? Dr. Christopher Lieu breaks it down in this Clinic Conversation of the Week.
Read the full interview: www.youtube.com/watch?v=j2Hm...
#ClinicConversation #CheckMate8HW #ColorectalCancer
Read the full interview: www.youtube.com/watch?v=j2Hm...
#ClinicConversation #CheckMate8HW #ColorectalCancer
Clinic Conversation: CheckMate 8HW Study and the Future of Immunotherapy in Colorectal Cancer
YouTube video by Oncology Data Advisor
www.youtube.com
March 11, 2025 at 7:56 PM
How will the CheckMate 8HW trial impact the treatment of metastatic colorectal cancer (MSI-H/dMMR)? Dr. Christopher Lieu breaks it down in this Clinic Conversation of the Week.
Read the full interview: www.youtube.com/watch?v=j2Hm...
#ClinicConversation #CheckMate8HW #ColorectalCancer
Read the full interview: www.youtube.com/watch?v=j2Hm...
#ClinicConversation #CheckMate8HW #ColorectalCancer
HER2 alterations in NSCLC are paving the way for new targeted therapies—but testing is key!
In Module 1, Dr. Julia Kathleen Rotow breaks down HER2 biomarker testing guidelines and treatment strategies for clinicians. Learn more! bit.ly/3VxqUC5
#LungCancer #HER2
In Module 1, Dr. Julia Kathleen Rotow breaks down HER2 biomarker testing guidelines and treatment strategies for clinicians. Learn more! bit.ly/3VxqUC5
#LungCancer #HER2
March 9, 2025 at 4:31 PM
HER2 alterations in NSCLC are paving the way for new targeted therapies—but testing is key!
In Module 1, Dr. Julia Kathleen Rotow breaks down HER2 biomarker testing guidelines and treatment strategies for clinicians. Learn more! bit.ly/3VxqUC5
#LungCancer #HER2
In Module 1, Dr. Julia Kathleen Rotow breaks down HER2 biomarker testing guidelines and treatment strategies for clinicians. Learn more! bit.ly/3VxqUC5
#LungCancer #HER2
New immunotherapies & targeted therapies are transforming RCC treatment—but managing toxicities is key to patient safety.
Join Nazy Zomorodian, NP, for expert insights on optimizing RCC care: bit.ly/4e0qWbW
#KidneyCancer #RCC #RenalCellCarcinoma
Join Nazy Zomorodian, NP, for expert insights on optimizing RCC care: bit.ly/4e0qWbW
#KidneyCancer #RCC #RenalCellCarcinoma
March 7, 2025 at 4:23 PM
New immunotherapies & targeted therapies are transforming RCC treatment—but managing toxicities is key to patient safety.
Join Nazy Zomorodian, NP, for expert insights on optimizing RCC care: bit.ly/4e0qWbW
#KidneyCancer #RCC #RenalCellCarcinoma
Join Nazy Zomorodian, NP, for expert insights on optimizing RCC care: bit.ly/4e0qWbW
#KidneyCancer #RCC #RenalCellCarcinoma
What you need to know about #hemophilia #prophylaxis, all in one place.
Explore ISTH’s take on the latest guidelines and improve your practice today: ow.ly/475t50Vaxzt
#ISTHGuidelines #MedicalEducation #HealthCareProfessionals
Explore ISTH’s take on the latest guidelines and improve your practice today: ow.ly/475t50Vaxzt
#ISTHGuidelines #MedicalEducation #HealthCareProfessionals
March 5, 2025 at 5:18 PM
What you need to know about #hemophilia #prophylaxis, all in one place.
Explore ISTH’s take on the latest guidelines and improve your practice today: ow.ly/475t50Vaxzt
#ISTHGuidelines #MedicalEducation #HealthCareProfessionals
Explore ISTH’s take on the latest guidelines and improve your practice today: ow.ly/475t50Vaxzt
#ISTHGuidelines #MedicalEducation #HealthCareProfessionals
Von Hippel-Lindau disease (VHL) is a complex genetic disorder requiring a multidisciplinary approach. Join Dr. Eric Jonasch as he explores the latest insights into VHL management, from targeted therapies to early intervention strategies. Complete now: bit.ly/4c9mu9K
March 3, 2025 at 5:15 PM
Von Hippel-Lindau disease (VHL) is a complex genetic disorder requiring a multidisciplinary approach. Join Dr. Eric Jonasch as he explores the latest insights into VHL management, from targeted therapies to early intervention strategies. Complete now: bit.ly/4c9mu9K
Starting at 10 AM EST! Rare Disease Day Live Panel – You don't want to miss it. Join Oncology Data Advisor & Cancer Support Community for a vital discussion on rare diseases in clinical care, advocacy, and research.
Watch live here 👉 youtube.com/live/zIs8bEd...
Watch live here 👉 youtube.com/live/zIs8bEd...
Rare Disease Day 2025: Generating Change Through Patient-Centered Care
YouTube video by Oncology Data Advisor
youtube.com
February 28, 2025 at 2:25 PM
Starting at 10 AM EST! Rare Disease Day Live Panel – You don't want to miss it. Join Oncology Data Advisor & Cancer Support Community for a vital discussion on rare diseases in clinical care, advocacy, and research.
Watch live here 👉 youtube.com/live/zIs8bEd...
Watch live here 👉 youtube.com/live/zIs8bEd...
For oncologists and screening professionals: Module 3 with Dr. Charles Vega explores implementing MCED testing in clinical settings through real-life cases. Listen today to learn more: bit.ly/4csyZxq
#ClinicalPractice #MCEDTesting #Oncology #CancerScreening
#ClinicalPractice #MCEDTesting #Oncology #CancerScreening
February 20, 2025 at 2:15 PM
For oncologists and screening professionals: Module 3 with Dr. Charles Vega explores implementing MCED testing in clinical settings through real-life cases. Listen today to learn more: bit.ly/4csyZxq
#ClinicalPractice #MCEDTesting #Oncology #CancerScreening
#ClinicalPractice #MCEDTesting #Oncology #CancerScreening